These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36338506)

  • 1. Hospitalized Patients With COVID-19 Have Higher Plasma Aldosterone-Renin Ratio and Lower ACE Activity Than Controls.
    Parikh NI; Arowolo F; Durstenfeld MS; Nah G; Njoroge J; Vittinghoff E; Long CS; Ganz P; Pearce D; Hsue P; Wu AHS; Hajizadeh N; Liu KD; Lynch KL
    J Endocr Soc; 2022 Oct; 6(12):bvac144. PubMed ID: 36338506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
    Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
    Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2.
    Zimmermann T; Walter JE; Lopez-Ayala P; Strebel I; Amrein M; Koechlin M; Honegger U; Mueller C;
    ESC Heart Fail; 2021 Apr; 8(2):1717-1721. PubMed ID: 34596976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The systemic renin-angiotensin system in COVID-19.
    Reindl-Schwaighofer R; Hödlmoser S; Domenig O; Krenn K; Eskandary F; Krenn S; Schörgenhofer C; Rumpf B; Karolyi M; Traugott MT; Abrahamowicz A; Tinhof V; Mayfurth H; Rathkolb V; Mußnig S; Schmölz L; Ullrich R; Heinzel A; König F; Binder C; Bonderman D; Strassl R; Puchhammer-Stöckl E; Gorkiewicz G; Aberle JH; Jilma B; Wenisch C; Poglitsch M; Oberbauer R; Zoufaly A; Hecking M
    Sci Rep; 2022 Nov; 12(1):20117. PubMed ID: 36418458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
    Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
    Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
    Coto E; Avanzas P; Gómez J
    Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
    Cadegiani FA; Goren A; Wambier CG
    Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019.
    Camargo RL; Bombassaro B; Monfort-Pires M; Mansour E; Palma AC; Ribeiro LC; Ulaf RG; Bernardes AF; Nunes TA; Agrela MV; Dertkigil RP; Dertkigil SS; Araujo EP; Nadruz W; Moretti ML; Velloso LA; Sposito AC
    Front Cardiovasc Med; 2022; 9():847809. PubMed ID: 35811697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
    Melissa Hallow K; Dave I
    Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
    Lumbers ER; Head R; Smith GR; Delforce SJ; Jarrott B; H Martin J; Pringle KG
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00917. PubMed ID: 35106954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases.
    Neves RL; Branquinho J; Arata JG; Bittencourt CA; Gomes CP; Riguetti M; da Mata GF; Fernandes DE; Icimoto MY; Kirsztajn GM; Pesquero JB
    Inflamm Res; 2023 Aug; 72(8):1719-1731. PubMed ID: 37537367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ACE activity and plasma ACE concentration in patients with SARS-CoV-2 infection.
    Henry BM; Benoit JL; Rose J; de Oliveira MHS; Lippi G; Benoit SW
    Scand J Clin Lab Invest; 2021 Jul; 81(4):272-275. PubMed ID: 34003706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.